ecrin-mdr-crcClinical2018Colorectal CancerColorectal NeoplasmsColorectal cancer (CRC)Metastatic colorectal cancerMetastatic Colorectal CancerColorectal Cancer (crc)Colorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2275230South KoreaUnited StatesUnited KingdomAustraliaFranceSwitzerlandSpain9IMPRIME PGGSelicrelumabISATUXIMABREGORAFERIBIdasanutlinAtezolizumabBevacizumabECRIN MDRTerminatedfalseA Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)A phase Ib/II, open-label, multicenter, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of immunotherapy-based treatment combinations in patients with metastatic colorectal cancer (mCRC) that became refractory to first- and second-line standard therapies. Eligible patients will be assigned to one of several treatment arms.2018-09-152275230NCT035551492017-004566-99